No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
TSVT 2seventy bio
- 3.140
- +0.220+7.53%
Close Dec 20 16:00 ET
- 3.140
- 0.0000.00%
Post 20:05 ET
161.99MMarket Cap-1.72P/E (TTM)
3.190High2.870Low900.11KVolume2.870Open2.920Pre Close2.77MTurnover2.04%Turnover RatioLossP/E (Static)51.59MShares6.40052wk High0.71P/B138.60MFloat Cap2.78052wk Low--Dividend TTM44.14MShs Float64.000Historical High--Div YieldTTM10.96%Amplitude1.535Historical Low3.074Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
2seventy Bio: Buy Rating Amidst Challenges and Growth Potential in BCMA CAR-T Therapy
2seventy Bio (TSVT) Gets a Hold From Morgan Stanley
US$8.25: That's What Analysts Think 2seventy Bio, Inc. (NASDAQ:TSVT) Is Worth After Its Latest Results
When Will 2seventy Bio, Inc. (NASDAQ:TSVT) Become Profitable?
2seventy Bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Goldman Sachs Maintains 2seventy Bio(TSVT.US) With Sell Rating, Maintains Target Price $2
Heat List
US
Overall
Symbol
Price
% Chg
No Data